ArticleOncoimmunology2026

Efficacy and safety of cabozantinib plus nivolumab in advanced non-clear cell renal cell carcinoma: a nationwide multicenter study.

Chang Gon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.